1. Carbon dioxide titration curves were determined in vivo in dog and man at various degrees of acute non-respiratory acidaemia and alkalaemia.
Introduction
A method for the assessment of states of acute acidaemia in both dog and man, based on the CO 2 titration curves of blood in vivo, has been previously described (Kappagoda, Linden & Snow, 1970; Stoker, Kappagoda, Grimshaw & Linden, 1972) . These authors introduced the use of the non-133 respiratory pH of arterial blood as the index of the non-respiratory component of an acute acidaemia. The non-respiratory pH is defined as the pH which would occur if the Pco, of arterial blood (Pa,C02) were adjusted in vivo to 5·32 kPa (40 mmHg). It is well known that the CO 2 titration curve for blood in vivo differs significantly from that obtained for blood in vitro. This difference is one reason why the assessment of acid-base disturbances by methods based on the CO 2 titration curve of blood in vitro (e.g. Astrup, Jorgensen, Siggaard-Anderson & Engel, 1960) can lead to significant errors when applied to the whole body (Stoker et 01., 1972) . The method previously described (Kappagoda et 01., 1970; Stoker et 01., 1972) avoids these errors, but so far it has only been developed to allow assessment of acute states of acidaemia.
In this paper this method has been extended to be of use in the assessment of acute acid-base disturbances in patients with an alkalaemia and in patients with chronic respiratory and chronic renal disease. Results obtained in states of acute alkalaemia, and additional results from the normal state, have been considered along with previously published data (Kappagoda et 01.,1970; Stoker et al., 1972; Kappagoda, Stoker, Snow & Linden, 1972) to provide a comprehensive account of all acute acid-base disorders, thus extending the application of this method to include states of acute alkalaemia. Data from both man and dog have been combined and analysed collectively, since it has been shown that there is no significant difference in the respective slopes of the CO 2 titration curves in vivo (e.g. Brackett, Cohen & Schwarz, 1965; Stoker et al., 1972) . In addition CO 2titration curves were obtained in patients with chronic acid-base disturbances secondary to both renal disease and chronic CO. retention. The nature of these CO. titration curves were compared with those obtained in patients with acute acid-base disturbances to show that the scheme proposed for acute acid-base disturbances can also be applied to these patients,
Methods

Carbon dioxide titration curves in acute acid-base disturbances
A series of CO. titration curves in vivo was obtained in twenty-two human subjects and twelve anaesthetized dogs.
Of the human subjects, eleven were studied during open heart surgery, when an acute non-respiratory acidaemia occurred spontaneously, two after a massive pulmonary embolus, one with a minor barbiturate overdose with alkalosis due to repeated gastric lavage and a further eight at routine pre-operative diagnostic cardiac catheterization. Clinical details and serial measurements of pH, Pco, and Po. are given in Clinical Science and Molecular Medicine Table 74/14, deposited with the Librarian, The Royal Society of Medicine, 1 Wimpole Street, London WI M 8AE, from whom copies may be obtained on request.
The dogs were rendered acidaemic and alkalaemic by the intravenous infusions of 1 mol/l HCl and 1 mol/I NaHC03 respectively. The experimental details and protocol for obtaining CO. titration curves in vivo have been described previously (Kappagoda et al., 1970; Stoker et al., 1972; Kappagoda et al., 1972) . Arterial blood was withdrawn into heparinized syringes and analysed for pH, Pco, and Po» After control samples were obtained the Pa.co, was increased by the addition of CO. in concentrations of up to 10% to the inspired gas and decreased by hyperventilation. Blood samples were obtained 5-10 min after the start of each change in inspired air composition or ventilation. The procedure was completed by returning the ventilation to its initial value and final control samples were obtained. Only titration curves in which the initial and final control non-respiratory pH values differed by less than 0·02 pH unit were accepted for analysis.
Carbon dioxide titration curves in chronic acid-base disturbances
Carbon dioxide titration curves were obtained in seven patients with chronic renal disease and seven patients with chronic respiratory disease and CO 2 retention. The relevant clinical details of these patients are given in Clinical Science and Molecular Medicine Table 74/14, deposited with the Librarian, The Royal Society of Medicine. These studies were completed with the patients in a stable state with respect to their respiratory and renal function. The experimental protocol adopted for the determination of the CO. titration curves in these patients has been published previously .
The aims of this study were explained to the patients and their consents obtained before commencement of the investigation. The ethics of the investigation were approved at Killingbeck Hospital.
Results
Carbon dioxide titration curves in acute acid-base disturbance
A total of forty-eight CO. titration curves in vivo were obtained, twenty-eight curves in twenty-two human subjects and twenty curves in twelve dogs, and regression lines calculated for each. Two parameters were obtained from each titration curve: the slope (Alog Peo./ApH) and the pH at Pa.co, 5·32 kPa (40 mmHg), i.e, the non-respiratory pH.
The relationship between the slope (Alog Peo./ ApH) and the non-respiratory pH was determined by curvilinear regression analysis (Snedecor & Cochran, 1967) .The best fit to the data was obtained by using a third degree polynomial, represented by the following equation (higher degree polynomials did not significantly reduce the sum of the deviations from regression):
where y = slope (Alog Peo./ApH) and x = nonrespiratory pH. This cubic equation fitted the data significantly better than linear (P<O·OI) or quadratic (P<0·05) ones. The standard errors for the coefficients of the above equation were: 181·05 ± 54-S; 42·2±17·4; 1·706±2·172; 0-095 ±0·12.
A plot of all the data obtained and the calculated regression curve are shown in Fig. 1 . Also shown are the 95% confidence limits for the regression curve and the 95% tolerance limits for a single estimate of slope from a given value of the non-respiratory pH. From the above equation it is apparent (see Fig. 1 ) that the slope of the CO. titration curve in vivo becomes steeper with increasing non-respiratory acidaemia and decreases with non-respiratory alkalaemia and approaches -1. By the use of this relationship a family of CO. titration curves in vivo has been constructed (Fig. 2) . 
Examples of CO 2 titration curves in vivo in patients with chronic non-respiratory acidaemia (e) and chronic respiratory acidaemia (0).
FIG. 2. Carbon dioxide titration curves in vivo
constructed from the curvilinear relationship illustrated in Fig. 1 . The non-respiratory pH during an acute acidaemia can be obtained from the arterial pH and Pa,co2 as follows: the relevant point is plotted on this diagram and the titration curve in vivo is drawn through it; the pH value on this curve, corresponding to Pa,co2 5·32 kPa is the non-respiratory pH. Below the curves a table provides a clinical record sheet for the maintenance of chronological details of the acid-base status of the subject. .. 
Carbon dioxide titration curves in chronic acid-base disturbances
Fourteen CO 2 titration curves were obtained from patients with chronic acid-base disturbances; seven were from patients with chronic renal disease and seven from patients with chronic respiratory disease. Examples of titration curves from each group are shown in Fig. 3 . For the purpose of statistical analysis regression lines were constructed and two parameters were considered for each curve; the slope (.~log Pa,co2/ApH) and the pH at Pa.co, 5·32 kPa (40 mmHg) (Table 74/14). The relationship between these two parameters in patients with chronic renal disease is represented by the equation y = -2·34x +18'3, where y = AlogPa,co2/ApH and x = nonrespiratory pH. The corresponding relationship for the patients with chronic respiratory disease is represented by the equation y = -1'78x + 14'6, where y = AlogPa,co2/ApH and x = non-respiratory pH.
Over the range of values of non-respiratory pH studied, both the above regression lines, which relate slope to non-respiratory pH, lie within the 95% confidence limits of the regression lines for the total population (Fig. 4) .
Discussion
It has been shown previously that the slope of the CO 2 titration curve (i.e. Alog Pa,co2/ApH) of blood in vivo becomes steeper as the non-respiratory pH decreases (Kappagoda et al., 1970; Stoker et al., 1972) . Also the relationship between the nonrespiratory pH and the slope of the CO 2 titration curve in states of acute non-respiratory acidaemia was described by a linear regression equation. The additional data, reported here, were obtained from subjects who were either within the normal range of pH and Pa.co, or were in a state of chronic nonrespiratory acidaemia or alkalaemia. For instance chronic CO 2 retention leads to a high plasma bicarbonate and a high non-respiratory pH. We have compared the slopes of the CO 2 titration curves in this situation (i.e. a chronically elevated non-respiratory pH) with the slopes of the CO 2 titration curves in states where the non-respiratory pH is acutely elevated. A comparable analysis was also made in patients with chronic non-respiratory acidaemia. In this way, it was possible to determine whether the relationship between the slope and the non-respiratory pH which was found in acute acidbase disturbances is applicable to the chronic situation.
Thus it is now possible to extend the range over which the relationship between the non-respiratory pH and the slope of the CO 2 titration curve may be defined. The results show that over this extended range the relationship is curvilinear (Fig. 1) , and appears to be in agreement with the mathematical model proposed by Wolff (1967) and referred to by Russell, Illickal, Maloney, Rocher & Deland (1972) .
The slope of the CO 2 titration curve in vivo is dependent on the function of numerous buffering systems in the whole body (see Roos & Thomas, 1967) and not those in blood alone. Thus in diseases which result in chronic acid-base disturbances (e.g,
Non-respira tory pH Ingram et al. (1973) (A), Goldstein et al. (0) and Flenley et al. (1970) (e) are plotted against the data obtained in the present study. The curves shown are those described in Fig. 1 . The two points plotted from Ingram et al. (1973) refer to the slopes at chronic Pa.co, values of 4·47 kPa and 8·64 kPa respectively. The bar represents 2 x SEM. chronic renal disease) it is likely that in addition to the obvious effects on the plasma proteins and haemoglobin, other body proteins are also affected by the underlying disease. Thus a change in the buffering power of the whole body, as reflected in the slope of the CO2 titration curve in vivo, could be expected in these chronic acid-base disturbances. For instance, in patients with chronic renal disease, the regression line relating the slope (~log Pa,co2! pH) to the non-respiratory pH is below that in states of acute acidaemia (Fig. 4) . One could speculate, in these patients, that this results from a reduction in buffering power brought about by changes in body proteins similar to those observed in the plasma proteins and haemoglobin. The converse appears to be the case in the patients with chronic respiratory disease, probably as a result of the often concurrent polycythaemia. However, the present study has indicated that these changes in buffering power, with respect to CO2, while remaining an attractive hypothesis do not attain statistical significance. Thus in practice it becomes unnecessary to adopt a different system for the assessment of these chronic acid-base disturbances.
FIG. S. Results from
The slope of the acute CO 2 titration curve in subjects with chronic respiratory acidaemia has also been described by Flenley, Franklin & Millar (1970) , Goldstein, Gennari & Schwartz (1971) and Ingram, Millar & Tate (1973) . Data from these publications have been recalculated, in terms of~log Pco2!~pH and non-respiratory pH, and are compared with the results obtained in this study (Fig. 5) , where it will be seen that these previously obtained results of other authors all lie within the 95% confidence limits of the regression line obtained in this study. However, the values obtained by Goldstein et 01. (1971) must be treated with some caution since they did not measure PC02 but calculated PC02 from measurements of pH and CO2 content with the HendersonHasselbalch equation. The imprecision arising from such a procedure has been described by Linden & Norman (1971) . For our purposes to insert points on Fig. 5 it was therefore necessary to recalculate the values for PC02originally published by Goldstein et al. (1971) , the corrections to the pK' value of the Henderson-Hasselbalch equation proposed by Linden & Norman (1971) being used. Thus it may be concluded that in the groups of subjects so far studied, by us and other workers, the relationship between the non-respiratory pH and the slope of the CO 2 titration curve may be defined by a single equation.
The derived titration curves (Fig. 2) could therefore provide a simple method of assessing all disorders of acid-base balance as follows. The existence of a respiratory acid-base disorder is established by the determination of the Pa.co, and its severity is assessed in the conventional manner as the difference in the Pa.co, from the normal value. The presence of a non-respiratory disturbance is established by plotting the measured values (pH and Pa.cos) on the diagram shown in Fig. 2 . The displacement of this point from the normal line, i.e, the titration curve in vivo passing through pH 7·40 and Pa.co, 5·32 kPa (40 mmHg), indicates the existence of any non-respiratory disturbance. The magnitude of the disturbance is indicated by the non-respiratory pH, i.e. the pH at Pa.co, 5'32 kPa (40 mmHg), which is found by following the titration curve through the point.
Since the non-respiratory pH for anyone individual is predicted from a slope derived from a curve which is deduced from all our studies ( Fig. 1 and  Fig. 4) , this procedure will obviously incorporate a systematic error which accrues from the 95% tolerance limits for an individual value of this slope (see Fig. 1 ). For example, a patient with blood pH 7·245 and Pa.co, 6'6 kPa (50 mmHg) will have a non-respiratory pH of 7'32 and the 95% tolerance limits for this value will be ±0·026. These tolerance limits for the non-respiratory pH value should not detract from its use in the diagnosis of the nature of the acid-base disturbances. Further, in the treatment of such disturbances in a given patient it is relatively unimportant, as it is recommended that the analyses be repeated after any therapeutic intervention, such as an infusion of sodium bicarbonate in states of acute acidaemia. Since one is then investigating a changing state in a given individual the systematic error mentioned above diminishes in importance.
Thus the system may be used in each of the three groups of acid-base disturbance as a practical tool with which to follow the patient back to the 'normal' state. However, there is another major reason for advocating the use of non-respiratory pH as yet another method for assessing acute acid-base disorders. No methods, so far advocated, are capable of estimating (a) the total stores of buffers within the body or (b) whether these stores have decreased or increased since the beginning of the disease. It is not possible to predict from such measurements as base deficit or total buffer anion concentration in blood the amount of bicarbonate required to correct a non-respiratory acidaemia, even in acute disturbance. Such a difficulty is obviously increased in the chronic disturbance because of the long duration of the illness and the probable resulting change in the body store of buffers. The use of non-respiratory pH as an index in these disturbances, although the above difficulties are recognized, leaves the clinician with the choice of 'titrating' the patient back to a value which meets his clinical assessments. It also recognizes that correction of the acid-base state to a rigidly stipulated value such as a base deficit of zero in blood, or a non-respiratory pH value of 7,40, is probably not the best course of therapy for a patient who has a chronic acid-base disturbance. Thus a flexible system which permits the titration of the patient's acidaemia to a non-respiratory pH value which is considered optimum for each individual remains the most rational form of therapy for acid-base disorders.
